Cell Signaling Technology

Product Pathways - Growth Factors/Cytokines

Human TL1A/TNFSF15 (hTL1A) #11946


No. Size Price
11946LC 50 µg ( With Carrier ) ¥5,949.00 现货查询 购买询价
11946LF 50 µg ( Carrier Free ) ¥5,949.00 现货查询 购买询价
11946SC 10 µg ( With Carrier ) ¥2,061.00 现货查询 购买询价
11946SF 10 µg ( Carrier Free ) ¥2,061.00 现货查询 购买询价
11946 carrier free & custom formulation / quantityemail request
Applications Dilution Species-Reactivity Sensitivity MW (kDa) Isotype

Species cross-reactivity is determined by western blot.

Applications Key:

Source / Purification

Recombinant Human TL1A Leu72-Leu251 (Accession #NP_095150) was expressed in E.coli at Cell Signaling Technology. 

重组人TL1A Leu72-Leu251 (Accession #NP_095150)由CST公司在大肠杆菌中进行表达。

Molecular Characterization

Recombinant hTL1A has a calculated MW of 20,047Da. DTT-reduced protein migrates as a 21 kDa polypeptide. The nonreduced protein migrates as a 21 kDa monomer and 38 kDa cystine-linked homodimer. The expected amino terminus of recombinant hTL1A was verified by amino acid sequencing.

重组hTL1A的分子量为20,047Da。DTT还原蛋白接近21 kDa的多肽的迁移位置。非还原蛋白分为21kDa的单体和38kDa的胱氨酸联同型二聚体。重组hTL1A预期的氨基末端通过氨基酸测序进行了验证。


>95% as determined by SDS-PAGE of 6 μg reduced (+) and nonreduced (-) recombinant hTL1A. All lots are greater than 95% pure.

用6 μg还原的(+)和非还原的(-)重组hTL1A进行SDS-PAGE,纯度都大于95%。所有批次的产品纯度都大于95%。


The bioactivity of hTL1A was determined in a TF-1 cell viability assay. The ED50 of each lot is between 2-15 ng/ml. 

用TF-1细胞生存试验进行hTL1A的生物活性测定。每个批次的ED50在2-15 ng/ml之间。



The viability of TF-1 cells treated with increasing amounts of hTL1A in the presence of 10 µg/ml cyclohexamide was determined. After a 24 hr treatment with hTL1A, cells were incubated with tetrazolium salt and the OD450 - OD650 was determined.通过不断增加含10 µg/ml环己酰胺的hTL1A的量来测定TF-1细胞的生存力。用hTL1A作用24小时后,细胞中加入四唑盐继续培养,并测定OD450-OD650。

Coomassie Gel

Coomassie Gel

The purity of recombinant hTL1A was determined by SDS-PAGE of 6 µg reduced (+) and nonreduced (-) recombinant hTL1A and staining overnight with Coomassie Blue.重组hTL1A的纯度通过SDS-PAGE进行测定。用6 µg还原的(+)和非还原的(-)重组hTL1A进行SDS-PAGE,考马斯亮蓝染色过夜。


Less than 0.01 ng endotoxin/1 μg hTL1A.



With carrier: Lyophilized from a 0.22 μm filtered solution of hTL1A in 20 mM Tris, pH 7.2 containing 20 μg BSA per 1 μg hTL1A. Carrier free: Lyophilized from a 0.22 μm filtered solution of hTL1A in 20 mM Tris, pH 7.2.

有载体:将hTL1A溶液(20mM Tris,pH7.2,每1 μg hTL1A中含20 μg BSA)经0.22μm滤膜过滤并冻干。

无载体:将hTL1A溶液(20mM Tris,pH7.2)经0.22μm滤膜过滤并冻干。


TL1A (TNFSF15), a member of the TNF superfamily of proteins, is a splice variant of the TL1/VEGI gene (1). Endothelial cells, monocytes, macrophages, and dendritic cells express TL1A, which is upregulated by proinflammatory cytokines, microorganisms, and AMPK activation (1-4). TL1A activates the NF-κB and JNK pathways through its receptor, DR3 (1,5). TL1A may function as a costimulatory signal for T cell activation, specifically regulating Th17 cell development and proliferation (1,2,6). Mouse models suggest a role for TL1A as a driver for the inflammation and pathogenesis associated with inflammatory bowel disease (7,8).

TL1A (TNFSF15)是肿瘤坏死因子超家族成员之一,是TL1/VEGI基因的剪接变体(1)。内皮细胞、单核细胞、巨噬细胞和树突细胞都能表达TL1A,TL1A在促炎细胞因子、微生物和AMPK活化的作用下能上调(1-4)。TL1A通过其受体DR3能活化NF-κB和JNK通路(1,5)。TL1A可能作为T细胞活化的协同刺激信号,尤其是调节Th17细胞发育和增殖(1,2,6)。小鼠模型显示TL1A是炎性肠病相关炎症和发病机制的“驱动器”(7,8)。

Application References

Have you published research involving the use of our products? If so we'd love to hear about it. Please let us know!

For Research Use Only. Not For Use In Diagnostic Procedures.

Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.

Cell Signaling Technology® is a trademark of Cell Signaling Technology, Inc.

用户评论 --- 共 0


我要参与评论 :